Hospital
Ripon Medical Center INC
Ripon Medical Center INC was paid $4.30M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.
33Billing provider infoRIPON MEDICAL CENTER INC
RIPON, WI 54971
RIPON, WI 54971
33aNPI1053362624assigned 05/16/2006
33bProvider typeCritical Access Hospital
28Total paid$4.30M
24GClaims97,222
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#25 of 48
Median peer was paid$4.30M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,462 | $454K | |
| 2019 | 10,967 | $423K | |
| 2020 | 10,436 | $406K | |
| 2021 | 16,398 | $614K | |
| 2022 | 19,648 | $904K | |
| 2023 | 16,024 | $859K | |
| 2024incomplete | 11,287 | $635K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 3,866 | 3,035 | $690K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 16% | 5,500 | 4,572 | $686K |
| 96361 | Intravenous infusion, hydration; each additional hour | 14% | 2,291 | 1,255 | $594K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 4,403 | 3,076 | $552K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.7% | 3,718 | 3,213 | $415K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.4% | 2,499 | 2,174 | $275K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.8% | 2,015 | 1,304 | $207K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.8% | 1,061 | 858 | $204K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 360 | 313 | $96K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.8% | 971 | 497 | $76K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 451 | 369 | $74K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 2,550 | 924 | $64K |
79 more codes
| 80053 | Comprehensive metabolic panel | <1% | 6,482 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,133 | $26K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,251 | $26K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 172 | $25K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 920 | $22K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 275 | $21K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 103 | $14K |
| 84484 | <1% | 2,707 | $14K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 219 | $13K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 67 | $13K |
| 85610 | <1% | 1,933 | $12K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 228 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,029 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 556 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,423 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 140 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,999 | $8K |
| 83880 | <1% | 636 | $6K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 427 | $6K |
| G0378 | Hospital observation service, per hour | <1% | 123 | $6K |
| 81001 | <1% | 2,646 | $6K | |
| 83690 | <1% | 1,351 | $5K | |
| 83605 | <1% | 1,076 | $5K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,605 | $4K |
| 87081 | <1% | 679 | $3K | |
| 80306 | <1% | 289 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 588 | $3K |
| 97162 | <1% | 88 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,028 | $2K |
| 86140 | <1% | 1,094 | $2K | |
| 82077 | <1% | 316 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 545 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 28 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 53 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 197 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,830 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $1K |
| 87631 | <1% | 17 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 140 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 43 | $1K |
| 83735 | <1% | 422 | $1K | |
| 87077 | <1% | 265 | $985.65 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $977.46 |
| 85379 | <1% | 221 | $943.86 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,105 | $909.47 |
| 87040 | <1% | 150 | $892.60 | |
| 81025 | <1% | 142 | $798.04 | |
| 80179 | <1% | 80 | $686.35 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 28 | $635.71 |
| 81003 | <1% | 461 | $552.41 | |
| 87186 | <1% | 134 | $480.82 | |
| 80143 | <1% | 46 | $462.70 | |
| 85730 | <1% | 179 | $371.57 | |
| 73610 | <1% | 16 | $291.42 | |
| 73564 | <1% | 12 | $117.90 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,874 | $96.21 |
| 84703 | <1% | 13 | $77.70 | |
| 85027 | <1% | 34 | $73.59 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,684 | $73.31 |
| 80051 | <1% | 27 | $50.68 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,449 | $50.54 |
| 85378 | <1% | 14 | $50.15 | |
| 82565 | <1% | 28 | $37.03 | |
| 96376 | <1% | 145 | $34.79 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,325 | $30.31 |
| 82947 | <1% | 28 | $28.42 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,457 | $13.47 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 265 | $4.44 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 223 | $2.83 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 733 | $0.02 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 193 | $0.00 |
| A9270 | Non-covered item or service | 0% | 44 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 48 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 14 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 120 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 28 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 18 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINERATH, JOSEPH (SYSTEM DIRECTOR, GOV'T REIMB.)
| Provider | Location | Paid |
|---|---|---|
| SSM Health Care of Wisconsin, INC. | Madison, WI | $14.70M |
| SSM Health Care of Wisconsin INC | Baraboo, WI | $9.78M |
| SSM Health Care of Wisconsin, INC. | Janesville, WI | $8.37M |
| SSM Health Care of Wisconsin, INC | Madison, WI | $6.40M |
| Agnesian Healthcare INC | Fond Du Lac, WI | $2.25M |
| SSM Health Care of Wisconsin INC | Janesville, WI | $1.03M |
| Agnesian Healthcare INC | Fond Du Lac, WI | $172K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.